| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |